Anesthesia monitoring devices are the instruments that are used to assess a patient's response towards anesthetic drugs during a surgical procedure. They help the anesthetist to monitor and display the dose of anesthetic drugs used on the patient. The product types of anesthesia monitoring devices include advanced anesthesia monitors, basic anesthesia monitors, and integrated anesthesia workstations. Advanced anesthesia monitors include anesthesia gas monitors, depth of anesthesia monitors, and standalone capnography. Basic anesthesia monitors are used for oxygenation, ventilation, circulation, and body temperature measurements. The various applications of anesthesia monitoring devices include cardiology, neurology, dental, ophthalmology, urology, orthopaedics, and others. The end users of anesthesia monitoring devices include hospitals, ambulatory surgical centers, clinics, and nursing homes. The anesthesia monitoring devices market research report is one of a series of new reports from The Business Research Company that provides anesthesia monitoring devices market statistics, including anesthesia monitoring devices industry global market size, regional shares, competitors with anesthesia monitoring devices market share, detailed anesthesia monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the anesthesia monitoring devices industry. This anesthesia monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global anesthesia monitoring devices market size grew from $4.02 billion in 2022 to $4.45 billion in 2023 at a compound annual growth rate (CAGR) of 10.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The anesthesia monitoring devices market is expected to decline to $3.29 billion in 2027 at a CAGR of -7.2%. The increase in the number of surgeries globally is expected to propel the growth of the anesthesia monitoring devices market. The number of surgeries for hip fracture repair, neurosurgical procedures, cesarean section, and other surgeries is increasing, and therefore, in turn there is a rising demand for anesthesia monitoring devices. For instance, according to a study by British Journal of anesthesia, published in March 2021, the total number of surgical procedures carried out in England and Wales in 2020 was 3,102,674.  Most of the surgical procedures are cesarean section, neurosurgical procedures, intra-abdominal procedures, and orthopedic procedures. Also, there is an increase in the number of patients undergoing surgeries at ambulatory surgery centers. Therefore, the increasing number of surgeries will drive the anesthesia monitoring devices market. Technological advancements are a key trend gaining popularity in the anesthesia monitoring devices market. Many companies are launching new, technologically advanced products in the anesthesia monitoring devices industry. For example, in October 2020, Mindray, a company that manufactures medical equipment including anesthesia monitoring devices, announced the launch of brand new A9 and A8 anesthesia systems. These new anesthesia systems will help anesthesiologists and clinicians to maintain patient safety by using High Flow Nasal Cannula oxygen (HFNC) that extends the safe apnoeic time and also incorporates Automatic Controlled anesthesia (ACA) an assistive technology that automatically adjusts fresh gas and vaporizer output. In March 2020, AEONMED Group, a China-based company, completed acquisition of Heyer Medical AG for an undisclosed amount. The acquisition had taken place during the restructuring of Heyer Medical AG and will acquire Heyer’s anesthesia machines and medical ventilators product portfolio. Heyer Medical AG is a Germany-based medical device manufacturing company that mainly focuses on anesthesia machines and medical ventilators. Major players in the anesthesia monitoring devices market are Baxter International Inc., Cardinal Health, Draegerwerk AG & Co. KGaA, GE Healthcare, Heyer Medical AG, Intersurgical Limited, Medtronic Inc., Mindray Medical International Limited, Nihon Kohden Corporation, Philips Healthcare, Smiths Medical Inc., Infinium Medical, Fukuda Denshi Co. Ltd., Becton Dickinson and Company, Ambu S/A, Teleflex Incorporated, Ventlab, ACOMA Medical Industry Co., BPL Medical Technologies, Dixion GmbH, Löwenstein Medical GmbH & Co. KG, Medasense Biometrics Ltd., Veterinary anesthesia Systems Inc., CNSystems Medizintechnik GmbH, Allied Medical Limited, and Criticare Technologies Inc. North America was the largest region in the anesthesia monitoring devices market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anesthesia monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the anesthesia monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The anesthesia monitoring devices market consists of sales of clinician monitoring, Respiratory monitoring system, Circulatory system monitoring, and temperature monitoring system. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global anesthesia monitoring devices market is segmented - 1) By Product: Advanced Anaesthesia Monitors, Basic  Anesthesia Monitors, Integrated Anesthesia Workstation 2) By Application: Cardiology, Neurology, Dental, Ophthalmology, Urology, Orthopedics, Other Applications 3) By End User: Hospitals, Ambulatory Surgical Centers, Clinics, Nursing Homes

Patient monitoring devices are machines that are used to constantly monitor patients through various vital signs and warning systems to detect and record changes in patient health conditions. The main types of patient monitoring devices market are fetal and neonatal monitoring devices, weight monitoring and body temperature monitoring devices and equipment, vital parameter monitoring devices and equipment, and remote patient monitoring devices and equipment. Fetal and neonatal monitoring devices measure the heart rate and rhythm of the baby (fetus). This lets the healthcare providers see how the baby is doing. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The end-users are hospitals and clinics, diagnostic laboratories, and others. The patient monitoring devices market research report is one of a series of new reports from The Business Research Company that provides patient monitoring devices market statistics, including patient monitoring devices industry global market size, regional shares, competitors with a patient monitoring devices market share, detailed patient monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the patient monitoring devices industry. This patient monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global patient monitoring devices market grew from $23.46 billion in 2022 to $25.53 billion in 2023 at a compound annual growth rate (CAGR) of 8.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The patient monitoring devices market is expected to grow to $34.5 billion in 2027 at a CAGR of 7.8%. The demand for monitoring devices is likely to increase due to the shortage of professionals in the healthcare services industry. According to a report by Mercer, the US requires 2.3 million new healthcare workers by 2025; this includes nurses, physicians, lab technicians, and various other healthcare personnel. This shortage is likely to drive the demand for monitoring systems as these devices allow medical professionals to track multiple patients remotely. This is expected to drive the market for patient monitoring devices in the forecast period. Awareness of diseases is low in many countries across the globe, and this affected the demand for patient monitoring devices in the historic period. For instance, a study conducted by the Indian Council of Medical Research (ICMR) on 213 million people found that only 43.2% are aware of the chronic disease diabetes. This lack of disease awareness limited the diagnosis and treatment pool, thereby restricting market growth for patient monitoring devices. Patient monitoring device manufacturers are offering customized MPMs to cater to the growing patient pool. MPMs monitor different health parameters corresponding to patients’ health conditions. For instance, Infinium Medical’s Omni series monitors are preconfigured with ECG, oxygen saturation, non-invasive blood pressure, and temperature trackers. More advanced health measures such as invasive blood pressure, cardiac output, and anaesthetic agent measurement can be added to this device when needed. Custom MPM is predominantly beneficial for tracking the health status of critically ill patients. Major companies in the patient monitoring devices market include General Electric Company, Koninklijke Philips N.V., Draegerwerk AG, Cardinal Health, Inc., Masimo, Stryker Corporation, Medtronic Inc., Edwards Lifesciences, Flex Ltd., and Nihon Kohden Corporation. Asia-Pacific was the largest region in the global patient monitoring devices market in 2022. North America was the second-largest region in the global patient monitoring devices market. The regions covered in the patient monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the patient monitoring devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The patient monitoring devices market consist of sales of instruments such as blood pressure cuffs, glucometers, pulse oximeter, ECG + stethoscope, wearables (activity trackers and continuous monitoring), and thermometers for patient monitoring. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global patient monitoring devices market is segmented - 1) By Type: Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables Subsegments Covered: Fetal Monitoring Devices, Neonatal Monitoring Devices, Temperature Monitoring Devices, Weight Monitoring Devices, Cardiac Monitoring Devices, Neuromonitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Multiparameter Monitoring Devices, Cardiac Monitors, Respiratory Monitors, Hematological Monitors, Vital Parameter Monitors And Other End Users

Remote patient monitoring devices and equipment allow a patient to use a mobile medical device for a routine test and send the test data to a healthcare expert in real-time. The main type of device of remote patient monitoring devices and equipment are heart monitors, breath monitors, hematology monitors, and multi-parameter monitors. A heart monitor is a device that records the electrical activity of the heart. This device is the size of a pager. The various applications involved are cancer treatment, cardiovascular diseases, diabetes treatment, sleep disorders, weight monitoring, fitness monitoring, and other applications. The various end-users involved are home care settings, clinics, and hospitals. The remote patient monitoring devices and equipment market research report is one of a series of new reports from The Business Research Company that provides remote patient monitoring devices and equipment market statistics, including remote patient monitoring devices and equipment industry global market size, regional shares, competitors with a remote patient monitoring devices and equipment market share, detailed remote patient monitoring devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the remote patient monitoring devices and equipment industry. This remote patient monitoring devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global remote patient monitoring devices and equipment market size will grow from $1.18 billion in 2022 to $1.34 billion in 2023 at a compound annual growth rate (CAGR) of 13.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The remote patient monitoring devices and equipment market size is expected to grow to $2.14 billion in 2027 at a CAGR of 12.5%. The upcoming shortage of skilled healthcare professionals (doctors and nurses), drives the remote patient monitoring (RPM) devices and equipment market. As the number of patients with chronic diseases is increasing, it is getting difficult to monitor the patients due to operational time and cost-related issues. The rising number of patients with chronic diseases, increasing the need for monitoring, and projected shortfall in the number of nurses shortly increase the growth of remote patient monitoring devices and equipment. According to a report by Mercer, the US requires 2.3 million new health care workers by 2025; this includes nurses, physicians, lab technicians, and various other healthcare personnel. According to the Bureau of Labor Statistics, there is an additional need for 203,700 new registered nurses every year by 2026. However, only 438,100 nurses are expected to be added to 2026, which is way less than the demand. World Health Organization (WHO) projected that by 2030, low- and middle-income countries will have a deficit of 14.5 million healthcare professionals. The remote patient monitoring devices market is limited, as healthcare professionals are averse to adopting new technologies. Technologically advanced remote patient monitoring devices and equipment are adopted to reduce patients’ expenditure on hospitalization in terms of follow-up care. The rise of such adoption results in a reduction of hospital revenues. Therefore, hospitals and healthcare professionals resisted the adoption of remote patient monitoring systems and are limiting the market. For instance, a case study in the UK states, organizational barriers at various levels, technical, social, ethical, financial, and legal factors are restraining to investment, implementation action, and use of advanced patient monitoring systems. Remote patient monitoring device manufacturers are increasingly integrating IoT and wireless technology with remote patient monitoring devices to efficiently diagnose and treat medical conditions. Wireless sensor technology such as biosensor monitoring devices is multi-sensor systems implanted or embedded into the skin, consisting of a sensor that transmits data for real-time monitoring of a patient’s medical condition. IoT technology enables healthcare service providers to remotely monitor patients’ health parameters. These devices are miniaturized multi-sensing devices, aiding healthcare professionals to monitor blood pressure, blood glucose levels, and physiological parameters, and recommend the appropriate treatment. Major companies offering IoT and wireless sensor technology integrated patient monitoring devices include Xsensio, InSilixa, 1Drop Diagnostics, Kenzen. The remote patient monitoring device and equipment manufacturers must comply with the rules and regulations of the Health Insurance Portability and Accountability Act (HIPAA). These HIPAA regulations secure definitions of the network, take physical security, and process security measures regarding the Protected Health Information (PHI). Title II of HIPPA directs the Health and Human Services (HHS) of the U.S Department to manifest national standards for the exchange of electronic healthcare data and information. Health and Human Services (HHS). The Office for Civil Rights (OCR) issued guidance clarifying that cloud service providers and other business associates of healthcare organizations are covered by the HIPAA privacy, security, and breach notification rules for safe and secure electronic data interchange. In October 2021, Carbon Health, a US-based telemedicine company, acquired Alertive Healthcare for an undisclosed amount. The acquisition would accelerate Carbon Health’s omnichannel care delivery strategy and extend its portfolio in home-based care and remote patient care. Alertive Healthcare is a UK-based remote patient monitoring company. Major players in the remote patient monitoring devices and equipment market are Philips Healthcare, Honeywell, GE Healthcare, Medtronic, Boston Scientific, Johnson & Johnson, Biotronik, Robert Bosch, COVIDien PLC., and St. Jude Medical. Asia-Pacific was the largest region in the global remote patient monitoring devices and equipment market in 2022. North America was the second-largest region in the remote patient monitoring devices and equipment market. The regions covered in the global remote patient monitoring devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the remote patient monitoring devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The remote patient monitoring devices and equipment market consists of sales of instruments such as heart monitors, breath monitors, and multi-parameter monitors. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global remote patient monitoring devices and equipment market is segmented - 1) By Type Of Device: Heart Monitors, Breath Monitors, Haematology Monitors, Multi - Parameter Monitors 2) By End User: Home Care Settings, Clinics, Hospitals 3) By Application: Cancer Treatment, Cardiovascular Diseases, Diabetes Treatment, Sleep Disorder, Weight Monitoring And Fitness Monitoring, Other Applications

Veterinary patient monitoring equipment refers to a type of devices and instruments that continuously track and record changes in patient wellbeing, monitor animals' respiration, blood pressure, and other vital signs, and provide warning systems. These systems are used to continuously monitor the animals to detect diseases at early stages to prevent any risks. The main types of veterinary patient monitoring equipment are cardiac monitoring devices, respiratory monitoring devices, remote patient monitoring devices, multi-parameter monitoring devices, neuromonitoring devices, and other products. The cardiac monitoring devices refer to the devices that deal with animal cardiac diseases. These are used for animals such as small companion animals, large companion animals, wild animals, zoo animals, aquatic animals, and exotic animals. Veterinary patient monitoring equipment is used in veterinary hospitals, veterinary clinics, and veterinary research centers. The veterinary patient monitoring equipment research report is one of a series of new reports from The Business Research Company that provides veterinary patient monitoring equipment statistics, including veterinary patient monitoring equipment industry global market size, regional shares, competitors with veterinary patient monitoring equipment shares, detailed veterinary patient monitoring equipment segments, market trends and opportunities, and any further data you may need to thrive in the veterinary patient monitoring equipment industry. This veterinary patient monitoring equipment research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global veterinary patient monitoring equipment market size will grow from $0.42 billion in 2022 to $0.45 billion in 2023 at a compound annual growth rate (CAGR) of 7.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global veterinary patient monitoring equipment market size is expected to grow from $0.58 billion in 2027 at a CAGR of 6.4%. An increase in the prevalence rate of diseases among animals serves as one of the major drivers for the veterinary patient monitoring equipment market. An increase in the incidence of diseases in livestock and companion animals will require monitoring equipment to diagnose the diseases in animals. For instance, according to the Banfield Pet Hospital's 2020 Veterinary Emerging Topics (VET) Report, more than 50% of the dogs at 1,000 hospitals in 2019 were overweight or obese. Overweight pets are more likely to suffer from joint disease, respiratory disease, and other preventable conditions. The increase in the prevalence rate of diseases for animals results in an increased demand for enhanced veterinary patient monitoring equipment. Veterinary patient monitoring equipment is highly expensive. The cost of equipment will be a significant expense for a veterinary clinic or hospital. For instance, the average wearable device ranges from $50 to $100 and will likely have a recurring software as a service (SaaS) fee to store and retrieve an animal’s health data analytics. These expenses hinder the growth of the veterinary patient monitoring equipment market. Veterinarians and pet or cattle owners are shifting to wearable technology to keep track of animal behavior. Wearable technology is smart electronic devices that are worn on the body or integrated with clothing or accessories and monitor body temperature, behavior, and movement. These wearable monitoring devices provide timely insights regarding the overall health of the animal and help the veterinarian provide an appropriate diagnosis for the animal. For instance, Vetrax, a wearable sensor worn on a dog’s collar, enables clinicians and pet owners to monitor aspects of an animal’s behaviour when they are unsupervised. According to a report by Veterinary Practice News, 83% of pet owners are satisfied with the use of wearable technology and 68% find it an effective way of monitoring the weight and diabetes of their pets. The veterinary patient monitoring equipment market is regulated by government agencies such as the European Medicines Agency (EMA), USFDA (the US Food and Drug Administration), and others. The EMA should certify the medical devices before they are marketed. The EMA verifies the safety and quality of the devices before they can be certified and approved for use throughout the European Union. The EMA requires all devices to comply with the regulations stated under Directive 2001/82/EC and Regulation (EC) No. 726/2004. In August 2020, Merck Animal Health, a US-based company specializing in veterinary products, technologies, and services, acquired IdentiGEN Ltd. for an undisclosed amount. Through this acquisition, Merck offers animal monitoring for food producers, processors, and retailers who are searching for precise and comprehensive animal traceability solutions that offer full accountability as well as increased transparency, food quality, and sustainability for consumers. In combination with Merck's current identification and monitoring technology, which provides real-time, actionable data and insights to aid in, improve, or enhance animal management and health outcomes, the addition of specialized digital technology to our portfolio of medications, vaccines, and services offers comprehensive solutions to help advance animal health. IdentiGEN Ltd. is a land-based company pioneering in DNA-based analysis and diagnostics for animal health monitoring. Major players in the veterinary patient monitoring market are Smiths Group plc; Hallowell Engineering & Manufacturing Corporation; DRE Veterinary; Digicare Biomedical Technology Inc.; Midmark Corporation; Medtronic PLC.; Jorgensen Laboratories; Vetland Medical Sales and Services LLC; Jorgen Kruuse A/S; Mila International Inc.; and Mindray Medical International Limited. North America was the largest region in the veterinary patient monitoring market in 2022. Asia-Pacific was the second-largest region in the global veterinary patient monitoring market. The regions covered in the global veterinary patient monitoring equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the veterinary anesthesia equipment market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, and USA. The veterinary patient monitoring equipment market consists of sales of bedside patient monitoring systems, renal patient monitoring devices, circulatory system patient monitoring devices, and obesity patient monitoring devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global veterinary patient monitoring equipment market is segmented - 1) By Product: Cardiac Monitoring Devices, Respiratory Monitoring Devices, Remote Patient Monitoring Devices, Multi-Parameter Monitoring Devices, Neuromonitoring Devices, Other Products 2) By End User: Veterinary Hospitals, Veterinary Clinics, Veterinary Research Centers 3) By Animal: Small Companion Animals, Large Companion Animals, Wild Animals, Zoo Animals, Aquatic Animals, Exotic Animals

Fetal and neonatal monitoring devices are used to assess the fetal heart rate and contractions of the uterus during pregnancy and childbirth. The main equipment of fetal and neonatal monitoring devices and equipment are fetal and neonatal. Neonatal monitoring devices and equipment are used for the monitoring of various body parameters of the newborn. Portable or non-portable fetal and neonatal monitoring devices and equipment Fetal care equipment types are ultrasound devices, fetal dopplers, fetal MRI systems, fetal monitors, and fetal pulse oximeters. Neonatal care equipment types are infant warmers, incubators, convertible warmers and incubators, phototherapy equipment, respiratory devices, neonatal monitoring devices, and diagnostic imaging devices. The various end-users are hospitals, diagnostic centres, pediatric clinics, and ambulatory surgical centres. The fetal and neonatal monitoring devices and equipment market research report is one of a series of new reports from The Business Research Company that provides fetal and neonatal monitoring devices and equipment market statistics, including fetal and neonatal monitoring devices and equipment industry global market size, regional shares, competitors with a fetal and neonatal monitoring devices and equipment market share, detailed fetal and neonatal monitoring devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the fetal and neonatal monitoring devices and equipment industry. This fetal and neonatal monitoring devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global fetal and neonatal monitoring devices market size will grow from $7.62 billion in 2022 to $8 billion in 2023 at a compound annual growth rate (CAGR) of 4.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The fetal and neonatal monitoring devices market size is expected to grow to $9.31 billion in 2027 at a CAGR of 3.9%. The increasing prevalence of preterm births and the low body weight of infants act as a factor driving the fetal and neonatal monitoring devices market growth. Preterm birth refers to the premature birth of a child before 37 weeks gestation period, which leads to poor health and growth, mental retardation, visual and hearing impairments, cerebral palsy, and others. According to World Health Organization (WHO), around 1 million babies die each year and preterm birth was found to be one of the top reasons for the deaths. According to the report by WHO, nearly 15 million babies are born preterm every year and this number is expected to have a continuous rise shortly. The increasing prevalence and need to reduce the infant mortality rates with improving healthcare conditions drives the fetal and neonatal monitoring devices market. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2021 the preterm birth rate in American women was 10.5%. The fetal and neonatal monitoring device market is restricted by stringent regulatory policies governing this market. The fetal and neonatal device manufacturers need to pass through several tests and requirements laid down by different regulatory bodies. Regulations like FDA's Center for Devices and Radiological Health (CDRH), NMPA regulations, EU directives lay down some stringent regulations for this equipment. The changes related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes lead to increased healthcare costs. For instance, according to a report by Ernst and Young, Fortune 500 companies are spending $7.8 billion to comply with GDPR. The GDPR is an EU law on the data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). Furthermore, the FDA is requesting more clinical data to support claims resulting in increased processing times of 510(k)s by over 55% over the last decade, thus delaying the operating cycle of manufacturers in this market. Fetal and neonatal monitoring device manufacturers are increasingly innovating and integrating technologies such as wireless technology with patient monitoring devices to efficiently diagnose and monitor fetuses and newborns. Wireless sensor technology such as biosensor monitoring devices, wireless fetal heart rate monitoring devices is multi-sensor systems implanted or embedded into the skin, consisting of a sensor that transmits data for real-time monitoring of a patient’s medical condition. For instance, the National Institute of Neurological Disorders and Stroke developed SARA, a scanning device that can detect fetal brain activity with the help of flashes of light transmitted through the mother's abdomen. Philips developed a new cordless fetal monitoring device that helps in ensuring the safety of the mother as well as the child without any inconvenience and risk. These technological innovations eliminate poor reception of observation and help caregivers in monitoring more efficiently. Hong Kong’s Department of Health, a regulatory body for fetal and neonatal monitoring devices of Hong Kong, sent a medical device safety alert to Guangzhou Sunray Medical Apparatus Co., Ltd., a medical device manufacturer, concerning its maternal and fetal monitor. The safety alert was sent as the Guangzhou Sunray maternal and fetal monitor was delivering inaccurate ultrasound-derived fetal heart rate recordings due to software-related issues. These devices impacted patients’ health with delayed intervention resulting in severe injury or death to the fetus. To reduce incidences associated with these devices MRHA sent a medical device safety alert to correct the device. Similarly, in January 2021, Medtronic PLC., received Class II recall notice from the Food and Drug administration for its Neonatal valves due to problematic design. The faulty device resulted in shunt malfunction in certain cases. Major players in the fetal and neonatal monitoring devices and equipment market are GE Healthcare, Fisher & Paykel Healthcare Limited, Philips Healthcare, Atom Medical Corporation, Natus Medical Incorporated, Analogic Corporation, Phoenix Medical Systems (P) Ltd., Becton Dickinson, Masimo Corporation, and Drägerwerk AG & Co. KGAA Asia-Pacific was the largest region in the global fetal and neonatal monitoring devices and equipment market in 2022. North America was the second-largest region in the fetal and neonatal monitoring devices and equipment market. The regions covered in the global fetal and neonatal monitoring devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the fetal and neonatal monitoring devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia. The fetal and neonatal monitoring devices market consists of sales of instruments such as ultrasound devices, fetal dopplers, fetal MRI systems, fetal monitors, and fetal pulse oximeters. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global fetal and neonatal monitoring devices market is segmented - 1) By Equipment: Fetal, Neonatal 2) By End User: Hospitals, Diagnostic centers, Pediatric Clinics, Ambulatory Surgical Centers 3) By Portability: Portable, Non Portable 4) By Fetal Care Equipment Type: Ultrasound Devices, Fetal Dopplers, Fetal MRI Systems, Fetal Monitors, Fetal Pulse Oximeters 5) By Neonatal Care Equipment Type: Infant Warmers, Incubators, Convertible Warmers & Incubators, Phototherapy Equipment, Respiratory Devices, Neonatal Monitoring Devices, Diagnostic Imaging Devices

Vital parameter monitoring devices and equipment are used to monitor critical parameters such as blood pressure, heart rate, and other physiological parameters. The main product types of vital parameter monitoring devices and equipment are blood pressure monitoring devices, pulse oximeters, and temperature monitoring devices. Blood pressure monitoring devices are electronic devices that are used to monitor blood pressure. The blood pressure monitoring devices are aneroid BP monitors, digital BP monitors, ambulatory BP monitors, and blood pressure instrument accessories. The pulse oximeters are table-top/bedside pulse oximeters, fingertip pulse oximeters, hand-held pulse oximeters, wrist-worn pulse oximeters, and pediatric pulse oximeters. The temperature monitoring devices are digital thermometers, infrared thermometers, and temperature strips. The various end-users are hospitals, clinics, ambulatory surgery centres, and home care settings. The vital parameter monitoring devices and equipment market research report is one of a series of new reports from The Business Research Company that provides vital parameter monitoring devices and equipment market statistics, including vital parameter monitoring devices and equipment industry global market size, regional shares, competitors with a vital parameter monitoring devices and equipment market share, detailed vital parameter monitoring devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the vital parameter monitoring devices and equipment industry. This vital parameter monitoring devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global vital parameter monitoring devices and equipment market size will grow from $6.62 billion in 2022 to $7.13 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The vital parameter monitoring devices and equipment market size is expected to grow to $9.14 billion in 2027 at a CAGR of 6.4%. An increase in the geriatric population globally is driving the vital parameter monitoring devices and equipment market. Old people are more prone to medical conditions and diseases and require monitoring of vital health parameters. According to the World Health Organization, in 2020, there were about 1 billion people aged 65 years or above and the number is expected to reach 1.4 billion by 2030 and 2.1 billion by 2050.. The increasing number of old age patients seeking treatments and surgeries is contributing to market growth. The security concerns related to wireless vital parameter monitoring devices are acting as a restraint on the vital parameter monitoring devices and equipment market. Medical devices with features like wireless connectivity, remote monitoring, and near-field communication allow health professionals to monitor vital parameters like electrocardiogram (ECG), blood pressure (BP), and temperature from anywhere with convenience. These devices are connected to a broad network via IoT, making them potential entry points to larger hospital networks. This connectivity could be used by hackers to mount a ransomware attack against a large hospital and can hold the vital systems of the hospital hostage, or breach sensitive medical records. The medical data obtained in these types of attacks can be used for malicious activities like tax fraud or identity theft, and can even be used to track active drug prescriptions. According to Linchpinseo data 2022, Nearly 4 million connected devices monitor every part of the human body. Vital parameter monitoring devices and equipment companies are increasingly investing in the research and development of wearable health devices (WHDs). WHDs are smart electronic devices that can be worn by a consumer and are capable of tracking information related to health and fitness. These devices facilitate better monitoring of health and can help in early diagnosis and guidance from doctors. For instance, the ViSi Mobile developed by Sotera Wireless is a wearable device that can provide many vital parameters such as heart rate, respiration rate, oxygen saturation, pulse rate, etc. VitalTag is another wearable device developed as part of the Department of Homeland Security Science and Technology Directorate program to detect and monitor heart rate, blood oxygen levels, body temperature, and blood pressure. Current Health recently got FDA approval for an artificial intelligence-powered wearable device that monitors patient vital signs at the hospital and home. Vital parameter monitoring devices and equipment manufacturers are governed by the various quality and safety regulations. For instance, in the USA, the Food and Drug Administration's 510 (k) regulation for safety and effectiveness of vital parameter monitoring devices and equipment states that the device should be tested non-clinically for electrical safety, electromagnetic compatibility. Vital parameter monitoring devices and equipment are classified as class II under title 21, parts 800 to 898 by FDA. Class II devices are medical devices having a moderate risk. Major players in the vital parameter monitoring devices and equipment market are Welch Allyn (Hill-Rom Holdings), SunTech Medical (Halma plc), Masimo Corporation, General Electric Company, Medtronic PLC., Nihon Kohden Corporation, Koninklijke Philips N.V, A&D Company, Contec Medical Systems Co., and Nonin Medical. Asia-Pacific was the largest region in the global vital parameter monitoring devices and equipment market in 2022. North America was the second-largest region in the v tal parameter monitoring devices and equipment market. The regions covered in the global vital parameter monitoring devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the vital parameter monitoring devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The vital parameter monitoring devices and equipment market consist of sales of instruments such as blood pressure monitoring devices, pulse oximeters, and temperature monitoring devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global vital parameter monitoring devices and equipment market is segmented - 1) By Product Type: Blood Pressure Monitoring Devices, Pulse Oximeters, Temperature Monitoring Devices 2) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings 3) By Blood Pressure Monitoring Devices: Aneroid BP Monitors, Digital BP Monitors, Ambulatory BP Monitors, Blood Pressure Instrument Accessories 4) By Pulse Oximeters: Table-top/Bedside Pulse Oximeters, Fingertip Pulse Oximeters, Hand-held Pulse Oximeters, Wrist-worn Pulse Oximeters, Pediatric Pulse Oximeters 5) By Temperature Monitoring Devices: Digital Thermometers, Infrared Thermometers, Temperature Strips

Respiratory monitoring devices are used to assess the patient's respiratory organs and include patches that are placed on the body to measure respiration and heart rates. The main types of respiratory monitoring devices are capnographs, gas analyzers, pulse oximeters, peak flow meters, spirometers, polysomnography, and others. Capnographs are monitoring devices that measure the concentration of carbon dioxide in exhaled air and display a numerical readout and waveform tracing. The various applications involved are chronic obstructive pulmonary disease (COPD), infectious diseases, asthma, and others that are used by end-users such as laboratories, hospitals, and home use. The respiratory monitoring devices market research report is one of a series of new reports from The Business Research Company that provides respiratory monitoring devices market statistics, including respiratory monitoring devices industry global market size, regional shares, competitors with a respiratory monitoring devices market share, detailed respiratory monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory monitoring devices industry. This respiratory monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global respiratory monitoring devices market size will grow from $1.32 billion in 2022 to $1.46 billion in 2023 at a compound annual growth rate (CAGR) of 10.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global respiratory monitoring devices market size is expected to grow to $2.04 billion in 2027 at a CAGR of 8.7%. The market for respiratory monitoring devices is experiencing exponential growth due to the COVID-19 pandemic. The fact that COVID-19 is essentially a respiratory ailment has boosted the use of respiratory monitoring devices to monitor the physiological functions of the lungs during COVID-19 treatment. The rising rate of chronic respiratory diseases is expected to drive the respiratory monitoring devices market in the near future. Chronic respiratory diseases such as asthma, bronchitis, pneumonia, and others resulting from different bacterial and viral infections will boost the demand for respiratory monitoring devices. For example, in according to the National health survey 2021, 4.6% of adults agreed of ever been diagnosed with COPD, emphysema, and chronic bronchitis. Furthermore, according to the national vital statistics system, in 2020, COPD caused 152,657 deaths in the US and bronchitis caused 457 deaths in 2020. The respiratory monitoring devices such as spirometers and pulse oximeters act as essential devices to monitor vital respiratory parameters. The longer duration of time taken in the approval process of respiratory devices is restricting the growth of the respiratory monitoring devices market. Before a new respiratory device is introduced to the market, it takes 7.2 months for the FDA approval process, which adds to the development costs to be borne by device manufacturers, thus acting as a restraint to the market growth. To reduce incidences associated with respiratory devices and ensure that the devices are safe and have the least adverse reactions, regulatory authorities such as the Medicines and Healthcare products Regulatory Agency (MRHA) in the UK regulates and monitors the devices by restricting devices for use and sending field safety notices to correct the devices. These stringent approval processes and regulatory policies may impact the respiratory monitoring devices market. The companies in the market are increasingly launching smart respiratory monitoring devices to diagnose and monitor some respiratory diseases. These smart respiratory monitoring devices are Bluetooth-enabled and can be connected to smartphones to continuously monitor vital respiratory parameters. For instance, in February 2022, Aptar Pharma, a US-based manufacturer of drug delivery systems, launched HeroTracker® Sense. The new offering is a novel digital respiratory health solution that converts a standard meter dose inhaler into a smart connected healthcare device. It is useful for patients to track their MDI usage and help them stick to their prescribed doses. In June 2022, Senzime AB, a US-based manufacturer of patient monitoring systems, acquired Respiratory Motion for an initial cash payment of $19 million. The acquisition will help Senzime to expand its product portfolio in monitoring devices market and extend company’s capabilities. Respiratory motion is a US-based respiratory medical device manufacturer. Major players in the respiratory monitoring devices market are COVIDien, GE Healthcare, Philips Healthcare, ResMed, Siemens Healthcare, Merck & Co., Calando Pharmaceuticals, Quark Pharmaceuticals, Sirnaomics Inc., and Traversa Therapeutics. Asia-Pacific was the largest region in the respiratory monitoring devices market in 2022. North America was the second-largest region in the global respiratory monitoring devices market. The regions covered in the global respiratory monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the respiratory monitoring devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The respiratory monitoring devices market consists of sales of pulse oximeters, capnography, spirometers, polysomnography (PSG), peak flow meters, gas analyzers, and others that are used to monitor respiration and heart rate. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global respiratory monitoring devices market is segmented - 1) By Type: Capnographs, Gas Analyzers, Pulse Oximeters, Peak Flow Meters, Spirometers, Polysomnographs, Others Types 2) By End-User: Laboratories, Hospitals, Home Use 3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Infectious Diseases, Asthma, Other Applications

Temperature monitoring devices are the systems that control and regulate the temperature of a particular environment. They are used to track, control, and regulate the products’ temperature in a specific environment. The main types of temperature monitoring devices are contact-based temperature monitoring systems, and non-contact-based temperature monitoring systems. The non-contact-based temperature monitoring systems are used to measure the temperature of a person's or patient's body without being in contact with the object. The various applications involved are the oral cavity, rectum, ear, and others. The end-users involved are hospitals and surgical centres, nursing facilities, ambulatory care centers, home care, and others. The temperature monitoring devices market research report is one of a series of new reports from The Business Research Company that provides temperature monitoring devices market statistics, including temperature monitoring devices industry global market size, regional shares, competitors with a temperature monitoring devices market share, detailed temperature monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the temperature monitoring devices industry. This temperature monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global temperature monitoring devices market size will grow from $3.39 billion in 2022 to $3.77 billion in 2023 at a compound annual growth rate (CAGR) of 11.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global temperature monitoring devices market size is expected to grow to $5.45 billion in 2027 at a CAGR of 9.7%. The temperature monitoring devices market is experiencing massive growth due to the COVID-19 pandemic. Temperature monitoring of individuals or suspected patients is the first mode of diagnosis for COVID-19 used across various types of entities, including airports, offices, clinics, hospitals, and homecare. Also, infected patients' vital signs are required to be monitored both at hospitals and at home as a primary examination to track the infection. The increase in the prevalence of chronic and infectious diseases is causing a positive impact on the temperature monitoring devices market. Certain infectious diseases like Dengue, Zika, Malaria, Ebola require continuous monitoring of temperature to give appropriate treatment and save lives. Also, the temperature of patients with other chronic diseases such as cardiovascular diseases and kidney-related diseases has to be monitored continuously, especially when they are hospitalized as temperature monitoring gives an overview of their body functioning. Most recently, the COVID-19 pandemic has more than 19,365,157 active cases around the globe, and increased body temperature is one of the main symptoms of this disease, causing the demand for temperature monitoring devices to increase by several folds. Therefore, the prevalence of chronic and infectious diseases is expected to propel the market growth of temperature monitoring devices during the forecast period. The high cost of advanced temperature monitoring devices may hinder the growth of the temperature monitoring devices market. The average cost of thermometers ranges from US$1 to US$114. The high cost of these devices is due to the high costs of sensors used in them. This is a high amount for low-economic countries such as Africa., South America and several Asian countries. Thus, the high cost of temperature monitoring devices is hindering the growth of the temperature monitoring devices market. The companies in the temperature monitoring devices market are focusing on the manufacturing of wearable temperature monitoring devices. The wearable thermometer is a digital thermometer that measures the temperature by using a medium like a touch patch. It is connected to smart devices like phones, tablets, and laptops and allows continuous monitoring of temperatures. Products like the fit bit, apple watch, temperature strips, temperature patches are wearable temperature monitoring devices that are widely used for monitoring temperature. In December 2020, Celsium, a UK-based temperature monitoring device manufacturer launched world’s most accurate wearable thermometer. The new offering is 10X more accurate and has online platform support to take readings every four seconds and alert user when temperature rises. Major players in the temperature monitoring devices market are 3M Company, Drägerwerk AG & Co. KGaA, Cosinuss GmbH, Helen of Troy Limited, Koninklijke Philips N.V., Microlife Corporation, Omron Healthcare, Terumo Corporation, Welch Allyn, Inc., and C. R. Bard. North America was the largest region in the temperature monitoring devices market in 2022. Western Europe was the second largest region in the global temperature monitoring devices market. The regions covered in the global temperature monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the temperature monitoring devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The temperature monitoring devices market consists of sales of temperature monitoring sensors, smart temperature patches, and wearable continuous monitoring thermometers. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global temperature monitoring devices market is segmented - 1) By Type: Contact-based Temperature Monitoring Systems, Non-contact-based Temperature Monitoring System 2) By Application: Oral Cavity, Rectum, Ear, Other Applications 3) By End User: Hospital and Surgical Centers, Nursing Facilities, Ambulatory Care Centers, Home Care, Other End Users